Image

Etiology, Epidemiology and Prognostics of AKI

Etiology, Epidemiology and Prognostics of AKI

Recruiting
18-89 years
All
Phase N/A

Powered by AI

Overview

  • To investigate the etiology and epidemiology of acute kidney injury (AKI).
    • To find out risk factors associated with the occurence of AKI.
    • To find out risk factors related to the prognosis of AKI,focusing on uremic toxins, inflammation, oxidative stress and nutritional status.
    • To study on the relationship between gene polymorphism and prognosis of acute kidney injury.

Description

  1. To investigate the relationship between preexisting protein-energy wasting (PEW) and adverse outcomes in patients with AKI.
  2. To evaluate the association of serum nutritional variables and prognosis of AKI.
  3. Given the different half-lives of serum nutritional markers, we hypothesized that the utility of serum nutritional variables as prognostic predictors may differ in early death (<7 days) and late death (>7 days, <28 days) patients.
  4. To investigate the various kinds of uremic toxins in AKI, furthermore, to evaluate the relationship between uremic toxins, especially protein bound toxins, and short- or long-term mortality in AKI patients.
  5. To investigate the mineral bone disorders in AKI,and to evaluate whether these markers would role as prognostic predictors of AKI.
  6. Several risk factors of mortality in AKI,such as markers of PEW, inflammation and serum creatinine,have been used; however, no single indicator is considered to be a "gold standard."

Eligibility

Inclusion Criteria:

  • age >=18 years and <= 88 years
  • clinically diagnosed with acute kidney injury, according KDIGO criteria.

Exclusion Criteria:

  • preexisting chronic kidney failure (defined as an eGFR <60 ml/min per 1.73 m2)
  • post-renal obstruction or rapid progressive glomerulonephritis as the main cause of AKI
  • known acute renal dysfunction
  • hospital stays <24 hours
  • malignancy

Study details
    Acute Kidney Injury

NCT02967263

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

27 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.